1ESSI Stock Chart & Stats
€25.35
€0.83(3.41%)
At close: 4:00 PM EDT
€25.35
€0.83(3.41%)
Day’s Range― - ―
52-Week Range€12.00 - €40.00
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€16.84B
Enterprise Value€208.44B
Total Cash (Recent Filing)€6.56B
Total Debt (Recent Filing)€39.24B
Price to Earnings (P/E)16.9
Beta0.17
Next Earnings
Jan 21, 2027EPS Estimate
0.41Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)16.33
Shares Outstanding626,982,100
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.38
Price to Book (P/B)2.13
Price to Sales (P/S)1.32
P/FCF Ratio21.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€23.33Price Target Upside-7.96% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering5
EPS Forecast (FY)1.67
Revenue Forecast (FY)€12.74B
Bulls Say, Bears Say
Bulls Say
Personal Care Market ShareShare gains across branded Incontinence Care, Feminine Care and other Personal Care categories indicate stronger consumer and channel positioning. Because the gains translated into higher volume and sales, they support durable growth potential and better utilization of Essity’s established brands.
Balance Sheet StrengthLow net debt relative to EBITDA gives Essity meaningful financial flexibility while it funds acquisitions, innovation, dividends and restructuring. The stronger capital structure should improve resilience through cost volatility and preserve capacity for strategic investment over the next several quarters.
Cash GenerationEssity is generating positive and recently improving operating and free cash flow, providing internal funding for investment, shareholder distributions and debt management. Although conversion is moderate, the latest rebound supports the company’s ability to execute its strategy without relying heavily on external capital.
Bears Say
Weak Organic GrowthNegative organic growth shows that reported sales expansion currently depends on acquisitions and currency rather than broad-based underlying demand. This limits the durability of top-line growth and leaves Essity reliant on successful integration, pricing and recovery in weaker categories.
Input Cost And Margin PressureHigher raw material, energy and distribution costs have already reduced gross and group margins, while management expects further COGS pressure. Continued inflation can delay price recovery, constrain profitability and reduce the earnings benefit from savings initiatives.
Uneven Earnings QualityVolatile net income makes Essity’s earnings power less predictable even though operating margins remain solid. Uneven profitability can complicate capital allocation and weaken confidence that current returns will persist, particularly while restructuring and cost pressures remain elevated.
Essity AB News
1ESSI FAQ
What was Essity AB’s price range in the past 12 months?
Essity AB lowest stock price was €12.00 and its highest was €40.00 in the past 12 months.
What is Essity AB’s market cap?
Essity AB’s market cap is €16.84B.
When is Essity AB’s upcoming earnings report date?
Essity AB’s upcoming earnings report date is Jan 21, 2027 which is in 89 days.
How were Essity AB’s earnings last quarter?
Essity AB released its earnings results on Oct 22, 2026. The company reported €0.442 earnings per share for the quarter, beating the consensus estimate of €0.391 by €0.051.
Is Essity AB overvalued?
According to Wall Street analysts Essity AB’s price is currently Overvalued.
Does Essity AB pay dividends?
Essity AB does not currently pay dividends.
What is Essity AB’s EPS estimate?
Essity AB’s EPS estimate is 0.41.
How many shares outstanding does Essity AB have?
Essity AB has 626,982,100 shares outstanding.
What happened to Essity AB’s price movement after its last earnings report?
Essity AB reported an EPS of €0.442 in its last earnings report, beating expectations of €0.391. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Essity AB?
Currently, no hedge funds are holding shares in IT:1ESSI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Essity AB
Essity AB (publ) is a global manufacturer and distributor of personal care and wellness goods, along with related services. Its portfolio encompasses medical and healthcare items such as incontinence management solutions, wound care treatments, compression wear, orthopedic supports, skincare formulations, and advanced digital health tools featuring sensor technology. The company organizes its business into several divisions: Personal Care, Consumer Tissue, Professional Hygiene, and various other operations. Essity also manufactures a wide array of consumer products, including absorbent items (pads, diapers, washable absorbent underwear, menstrual cups, incontinence products), personal care items (wet wipes, skincare, intimate soaps), and paper goods (toilet papers, household towels, handkerchiefs, facial tissues, napkins). For professional settings, its hygiene offerings include restroom essentials (toilet papers, paper hand towels, napkins), hand care (soaps, lotions, sanitizers), dispensing systems, and cleaning/wiping solutions. Furthermore, the firm delivers digital innovations, particularly Internet of Things (IoT) sensor technology designed for data-driven facility management, alongside associated service and maintenance. These solutions cater to a diverse clientele, including corporate offices, educational institutions, healthcare providers, industrial sites, food service establishments, hospitality venues, sports arenas, and various other public spaces. Its medical and healthcare product lines, sold under brand names such as TENA, Leukoplast, Cutimed, JOBST, Actimove, and Delta-Cast, reach consumers through a variety of channels, including pharmacies, specialized medical device retailers, hospitals, authorized distributors, care facilities, and online platforms. Consumer products, featuring brands like Libero, Libresse, Nosotras, Saba, TOM Organic, Lotus, Regio, Tempo, and Vinda, are available via retail outlets and e-commerce. Professional hygiene items, branded as TORK, are distributed through intermediaries and digital storefronts. Essity's market presence extends across Europe, North America, Latin America, Asia, and other international regions. Established in 1849, Essity AB (publ) maintains its headquarters in Stockholm, Sweden.
1ESSI Company Deck
1ESSI Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a resilient but mixed quarter. Positive elements included stable group volumes, reported sales growth, market-share gains in Personal Care, progress in Feminine Care acquisitions, strong cash flow, a strong balance sheet, cost-saving execution and continued innovation. These were offset by negative organic sales growth, declines in Consumer Tissue, Baby Care and total Professional Hygiene volumes, substantial COGS inflation, margin contraction, elevated restructuring charges and expectations for further Q4 cost increases. Overall, the positive operational and strategic progress was balanced by significant cost and market pressures.View all IT:1ESSI earnings summaries1ESSI Net sales Breakdown
54.31% Consumer Goods
26.83% Professional Hygiene
18.84% Health & Medical
0.02% Other

1ESSI Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
€23.33
▼(-7.96% Downside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Zinzino AB
―
Midsona AB Class B
―
Duni AB
―
Humble Group AB
―
New Nordic Healthbrands AB
―







